Agrylin

Agrylin is a brand name of anagrelide, approved by the FDA in the following formulation(s):

AGRYLIN (anagrelide hydrochloride - capsule; oral)

• 
  Manufacturer: SHIRE LLC
  
  Approval date: March 14, 1997
  
  Strength(s): EQ 0.5MG BASE ^[AB]

Has a generic version of Agrylin been approved?

Yes. The following products are equivalent to Agrylin:

anagrelide hydrochloride capsule; oral

• 
  Manufacturer: ALPHAPHARM
  
  Approval date: June 27, 2006
  
  Strength(s): EQ 0.5MG BASE ^[AB]


• 
  Manufacturer: BARR
  
  Approval date: April 18, 2005
  
  Strength(s): EQ 0.5MG BASE ^[AB]


• 
  Manufacturer: IMPAX LABS
  
  Approval date: April 18, 2005
  
  Strength(s): EQ 0.5MG BASE ^[AB]


• 
  Manufacturer: IVAX SUB TEVA PHARMS
  
  Approval date: April 18, 2005
  
  Strength(s): EQ 0.5MG BASE ^[AB]


• 
  Manufacturer: MYLAN
  
  Approval date: April 18, 2005
  
  Strength(s): EQ 0.5MG BASE ^[AB]


• 
  Manufacturer: SANDOZ
  
  Approval date: April 18, 2005
  
  Strength(s): EQ 0.5MG BASE ^[AB]


• 
  Manufacturer: WATSON LABS
  
  Approval date: April 18, 2005
  
  Strength(s): EQ 0.5MG BASE ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Agrylin. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Agrylin.

See also...

• Agrylin Consumer Information (Wolters Kluwer)
• Agrylin Consumer Information (Cerner Multum)
• Agrylin Advanced Consumer Information (Micromedex)
• Agrylin AHFS DI Monographs (ASHP)
• Anagrelide Consumer Information (Wolters Kluwer)
• Anagrelide Consumer Information (Cerner Multum)
• Anagrelide Advanced Consumer Information (Micromedex)
• Anagrelide hydrochloride AHFS DI Monographs (ASHP)